Exogems SA is a Swiss biotech company developing exosome-based therapeutics for inflammation and regenerative medicine. The company works with the Lipogems® platform and proprietary technology to isolate and produce clinical-grade exosomes from adipose tissue.
AI-generated
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Isolation of exosomes from MSC-rich adipose tissue via the Lipogems® platform, using proprietary methods for consistent, scalable therapeutic exosomes.
Therapeutic exosomes for regenerative medicine and inflammation
Development of clinical exosome therapies for regenerative medicine and inflammation, with two therapeutic areas and four programs in clinical development.
Clinical exosome production with scalable manufacturing
Manufacture of clinical exosomes without cultivation, using a closed disposable device and scalable biopharmaceutical production know-how.
Comparisons
Exogems SA in comparison
Soon
Industry comparisons are coming soon
We're preparing industry comparisons that rank Exogems SA by reviews, experience and specialisations.
Knowledge
No knowledge articles yet
Once Exogems SA has claimed this profile, we'll publish editorial articles and case studies here together.